Skip to main content

Seth Rogen Is Launching His Own Marijuana Brand

AUSTIN, TEXAS – MARCH 11: Seth Rogen and Evan Goldberg attend the ‘Good Boys’ Premiere 2019 SXSW Conference and Festivals at Paramount Theatre on March 11, 2019 in Austin, Texas. (Photo by Matt Winkelmeyer/Getty Images for SXSW)

Getty

Seth Rogen and Evan Goldberg have worked together on films like Superbad, The Interview, and Pineapple Express. Now the duo is embarking on a different type of project: a marijuana company.

“Houseplant is a passion we’ve brought to life through drive and dedication,” said Seth Rogen, Co-Founder of Houseplant.  “Every decision we’ve made for the business reflects the years of education, first-hand experience and respect we have for cannabis.”

Based in Canada, the home country of both men, the brand’s first product is experienced to be called Houseplant Sativa and will be available in early April in British Columbia and surrounding areas. Afterward it plans to launch Houseplant Hybrid and Houseplant Indica, eventually followed by pre-rolled joints and gels. The cannabis it sells will come from Canada’s Canopy Growth, which also has a minority stake in the company.

“Houseplant represents years of product expertise and unmatched attention to detail within each strain that has been carefully selected and grown,” Canopy Growth said in a statement.“Commitment to cannabis quality begins with selecting the best genetics and doesn’t stop until the customer opens the jar. Canopy Growth has witnessed how carefully Houseplant has chosen each component of their offering to deliver the highest quality product to Canadians.”  

Rogen and Goldberg are fan from the first celebrities to join the cannabis space. Most recently, CJ Wallace, son of the Notorious B.I.G announced he was getting into cannabis with the launch of his brand Think Big, honoring his father.

In February both Martha Stewart and Willie Nelson also announced the launch of their own CBD brands. Like Rogen and Goldberg, Stewart is working with Canopy Growth on her line.

“I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,”  Stewart said in a statement. “I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets.”

Martha’s favorite pot luck guest Snoop Dogg also has his own CBD line in the works through Canopy Growth. Called “Leafs by Snoop” his line is expected to be made specifically to treat anxiety in pets.

Canopy Growth is a leading cannabis company in Canada but the company does not currently sell any products in the United States.

The company’s stock is currently traded on the New York Stock Exchange as well as the Toronto Stock Exchange. The NY stock exchange, in particular, does not allow companies traded on it from engaging in an enterprise that’s illegal on a federal level, which marijuana currently is in the United States.

Last year the company received a late influx for cash from Constellation Brands, the parent company of a number of well-known alcohol brands including Ballast Point Brewing and Corona.

Original Article Source: https://www.forbes.com/sites/emilyprice/2019/03/28/seth-rogen-is-launching-his-own-marijuana-brand/

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...